Breathlessness post-drainage predicts survival in patients with malignant pleural effusion

Breathlessness post-drainage predicts survival in patients with malignant pleural effusion

Bibliografski detalji
Glavni autori:	Mishra, E, Murugananandan, S, Clive, A, Davies, H, Stanton, A, Wrightson, J, Bhatnagar, R, Psallidas, I, Maskell, N, Lee, Y, Miller, R, Rahman, N
Format:	Conference item
Izdano:	BMJ 2018

Slični predmeti

P234 Patient and fluid characteristics associated with non-draining malignant pleural effusion
od: Mishra, E, i dr.
Izdano: (2017)

Survival in patients with malignant pleural effusion undergoing talc pleurodesis
od: Hassan, M, i dr.
Izdano: (2019)

THE USE OF INDWELLING PLEURAL CATHETERS FOR THE MANAGEMENT OF NON-MALIGNANT RECURRENT PLEURAL EFFUSIONS
od: Bhatnagar, R, i dr.
Izdano: (2012)

Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion
od: Asciak, R, i dr.
Izdano: (2017)

Intrapleural streptokinase in the drainage of malignant multiloculated pleural effusions
od: Davies, C, i dr.
Izdano: (1997)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion.
od: Morel, A, i dr.
Izdano: (2011)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion
od: Morel, A, i dr.
Izdano: (2011)

The palliation of malignant pleural effusions.
od: Bhatnagar, R, i dr.
Izdano: (2012)

Chemotherapy does not increase the risk of pleural infection in patients managed with an indwelling pleural catheter for malignant pleural effusion
od: Morel, A, i dr.
Izdano: (2010)

Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: The TAPPS RCT
od: Bhatnagar, R, i dr.
Izdano: (2020)

Randomised controlled trial of urokinase versus placebo for non-draining malignant pleural effusion
od: Mishra, E, i dr.
Izdano: (2018)

Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study
od: Psallidas, I, i dr.
Izdano: (2018)

Biological markers of successful pleurodesis for malignant pleural effusion
od: Psallidas, I, i dr.
Izdano: (2016)

Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT
od: Rahul Bhatnagar, i dr.
Izdano: (2020-06-01)

Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
od: Davies, H, i dr.
Izdano: (2012)

ERS/EACTS statement on the management of malignant pleural effusions
od: Bibby, A, i dr.
Izdano: (2018)

Outpatient talc administration by indwelling pleural catheter for malignant effusion
od: Bhatnagar, R, i dr.
Izdano: (2018)

Malignant pleural effusion management: keeping the flood gates shut
od: Walker, S, i dr.
Izdano: (2019)

Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice.
od: Bhatnagar, R, i dr.
Izdano: (2014)

Investigating suspected malignant pleural effusion.
od: Rahman, N, i dr.
Izdano: (2007)

Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion.
od: Penz, E, i dr.
Izdano: (2014)

EFFUSION SIZE ON THE CHEST RADIOGRAPH AT DAY 7 POST-PLEURAL DRAINAGE IS A GOOD PREDICTOR OF SIZE AT 3 MONTHS, REGARDLESS OF INITIAL INTRAPLEURAL THERAPY
od: Hallifax, R, i dr.
Izdano: (2012)

Assessment and treatment of malignant pleural effusions: visual analogue scale, ultrasound and drainage
od: Mishra, EK
Izdano: (2013)

Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.
od: Olfert, J, i dr.
Izdano: (2016)

Management of malignant pleural effusion: challenges and solutions
od: Penz, E, i dr.
Izdano: (2017)

Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.
od: Maskell, N, i dr.
Izdano: (2003)

ERS/EACTS statement on the management of malignant pleural effusions
od: Bibby, AC, i dr.
Izdano: (2018)

Novel mouse model of indwelling pleural catheter in mice with malignant pleural effusion
od: Merrick, C, i dr.
Izdano: (2019)

Pseudochylothorax without pleural thickening: time to reconsider pathogenesis?
od: Wrightson, J, i dr.
Izdano: (2009)

Pleural Fluid Resolution Is Associated with Improved Survival in Patients with Malignant Pleural Effusion
od: Christina R. MacRosty, i dr.
Izdano: (2023-05-01)

Survival and pleurodesis outcome in patients with malignant pleural effusion – post-hoc analysis from the TIME-1 trial
od: Hassan, M, i dr.
Izdano: (2018)

The Clinical Role and Reliability of Pleural Fluid Mesothelin in Undiagnosed Pleural Effusions.
od: Davies, H, i dr.
Izdano: (2009)

Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions.
od: Davies, H, i dr.
Izdano: (2009)

Echogenic swirling seen on ultrasound and outcome of pleurodesis in malignant pleural effusion
od: Hassan, M, i dr.
Izdano: (2019)

Objective thoracoscopic criteria in differentiation between benign and malignant pleural effusions
od: Ellayeh, M, i dr.
Izdano: (2021)

The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial.
od: Bhatnagar, R, i dr.
Izdano: (2015)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
od: Ellayeh, M, i dr.
Izdano: (2021)

Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists.
od: Lee, Y, i dr.
Izdano: (2003)

Pulmonary embolism developing after therapeutic drainage of malignant pleural effusions
od: Wang Chun Kwok, i dr.
Izdano: (2018-01-01)

Management of malignant pleural effusion
od: McCracken, D, i dr.
Izdano: (2018)